Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients [3]

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1834-1835

  Lepore, Giuseppe ^a   Dodesini, Alessandro R ^a   Nosari, Italo ^a   Trevisan, Roberto ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; AGE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTINUOUS SUBCUTANEOUS INSULIN INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; KETOACIDOSIS; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; RETROSPECTIVE STUDY; STUDENT T TEST; TREATMENT OUTCOME;

ADULT; AGE FACTORS; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; RETROSPECTIVE STUDIES;

EID: 21544444152     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1834     Document Type: Letter

References (8)

1. Linkeshova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 19:746-751, 2002
2. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 25:593-598, 2002
3. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324-327, 1996
4. Boland EA, Grey M, Osterle A, Fredrickson L, Tamborlane W: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22:1779-1784, 1999
5. Lepore G, Dodesini AR, Nosari I, Trevisan R: Both continuous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment (Letter). Diabetes Care 26:1321-1322, 2003
6. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26:1142-1146, 2003
7. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25:2074-2080, 2002
8. Siegel-Czarkowski L, Herold KC, Goland RS: Continuous subcutaneous insulin infusion in older patients with type 1 diabetes (Letter). Diabetes Care 27:3022-3023, 2004